173 related articles for article (PubMed ID: 36878356)
1. Cost-Effectiveness Analysis of Open Versus Endovascular Revascularization for Chronic Mesenteric Ischemia.
Patel RJ; Cui C; Khan MA; Willie-Permor D; Malas MB
Ann Vasc Surg; 2023 Aug; 94():347-355. PubMed ID: 36878356
[TBL] [Abstract][Full Text] [Related]
2. A comparison of open and endovascular revascularization for chronic mesenteric ischemia in a clinical decision model.
Hogendoorn W; Hunink MG; Schlösser FJ; Moll FL; Muhs BE; Sumpio BE
J Vasc Surg; 2014 Sep; 60(3):715-25.e2. PubMed ID: 24721175
[TBL] [Abstract][Full Text] [Related]
3. Cost-effectiveness of transcarotid artery revascularization versus carotid endarterectomy.
Cui C; Ramakrishnan G; Murphy J; Malas MB
J Vasc Surg; 2021 Dec; 74(6):1910-1918.e3. PubMed ID: 34182030
[TBL] [Abstract][Full Text] [Related]
4. Cost-effectiveness analysis of endovascular vs surgical arteriovenous fistula creation in the United States.
Mulaney-Topkar B; Ho VT; Sgroi MD; Garcia-Toca M; George EL
J Vasc Surg; 2024 Feb; 79(2):366-381.e1. PubMed ID: 37952783
[TBL] [Abstract][Full Text] [Related]
5. Long-term value in open and endovascular repair of chronic mesenteric ischemia.
Lehane D; Geiger J; Kedwai B; Zottola Z; Newhall K; Mix D; Doyle A; Stoner M
J Vasc Surg; 2024 Jan; 79(1):55-61. PubMed ID: 37709177
[TBL] [Abstract][Full Text] [Related]
6. Topotecan, pegylated liposomal doxorubicin hydrochloride and paclitaxel for second-line or subsequent treatment of advanced ovarian cancer: a systematic review and economic evaluation.
Main C; Bojke L; Griffin S; Norman G; Barbieri M; Mather L; Stark D; Palmer S; Riemsma R
Health Technol Assess; 2006 Mar; 10(9):1-132. iii-iv. PubMed ID: 16545208
[TBL] [Abstract][Full Text] [Related]
7. Cost-effectiveness of a paclitaxel-eluting stent (Eluvia) compared to Zilver PTX for endovascular femoropopliteal intervention.
Gray WA; Griffiths RI; Elroy PWM; Amorosi SL; McGovern AM; Jaff MR; Akehurst R; Müller-Hülsbeck S
J Med Econ; 2022; 25(1):880-887. PubMed ID: 35703041
[TBL] [Abstract][Full Text] [Related]
8. The Economic Impact of Acetabular Labral Tears: A Cost-effectiveness Analysis Comparing Hip Arthroscopic Surgery and Structured Rehabilitation Alone in Patients Without Osteoarthritis.
Lodhia P; Gui C; Chandrasekaran S; Suarez-Ahedo C; Dirschl DR; Domb BG
Am J Sports Med; 2016 Jul; 44(7):1771-80. PubMed ID: 27190068
[TBL] [Abstract][Full Text] [Related]
9. Pipeline embolization device versus coiling for the treatment of large and giant unruptured intracranial aneurysms: a cost-effectiveness analysis.
Wali AR; Park CC; Santiago-Dieppa DR; Vaida F; Murphy JD; Khalessi AA
Neurosurg Focus; 2017 Jun; 42(6):E6. PubMed ID: 28565986
[TBL] [Abstract][Full Text] [Related]
10. Cost-effectiveness of Recurrent Dupuytren Contracture Treatment.
Yoon AP; Kane RL; Hutton DW; Chung KC
JAMA Netw Open; 2020 Oct; 3(10):e2019861. PubMed ID: 33030553
[TBL] [Abstract][Full Text] [Related]
11. Cost-Effectiveness Analysis of Minimally Invasive Trabecular Meshwork Stents with Phacoemulsification.
Sood S; Heilenbach N; Sanchez V; Glied S; Chen S; Al-Aswad LA
Ophthalmol Glaucoma; 2022; 5(3):284-296. PubMed ID: 34563713
[TBL] [Abstract][Full Text] [Related]
12. Cost-effectiveness of ribociclib plus endocrine therapy versus placebo plus endocrine therapy in HR-positive, HER2-negative breast cancer.
Le V; Zhong L; Narsipur N; Hays E; Tran DK; Rosario K; Wilson L
J Manag Care Spec Pharm; 2021 Mar; 27(3):327-338. PubMed ID: 33645243
[No Abstract] [Full Text] [Related]
13. Cost-Effectiveness of Laparoscopic Hysterectomy With Morcellation Compared With Abdominal Hysterectomy for Presumed Myomas.
Rutstein SE; Siedhoff MT; Geller EJ; Doll KM; Wu JM; Clarke-Pearson DL; Wheeler SB
J Minim Invasive Gynecol; 2016 Feb; 23(2):223-33. PubMed ID: 26475764
[TBL] [Abstract][Full Text] [Related]
14. The clinical effectiveness and cost-effectiveness of cardiac resynchronisation (biventricular pacing) for heart failure: systematic review and economic model.
Fox M; Mealing S; Anderson R; Dean J; Stein K; Price A; Taylor RS
Health Technol Assess; 2007 Nov; 11(47):iii-iv, ix-248. PubMed ID: 17999842
[TBL] [Abstract][Full Text] [Related]
15. Cost-effectiveness of vibegron for the treatment of overactive bladder in the United States.
Chen JV; Klein TM; Nesheim J; Mudd PN
J Med Econ; 2022; 25(1):1092-1100. PubMed ID: 35993729
[TBL] [Abstract][Full Text] [Related]
16. UK cost-effectiveness analysis of endoscopic sleeve gastroplasty versus lifestyle modification alone for adults with class II obesity.
Kelly J; Menon V; O'Neill F; Elliot L; Combe E; Drinkwater W; Abbott S; Hayee B
Int J Obes (Lond); 2023 Nov; 47(11):1161-1170. PubMed ID: 37674032
[TBL] [Abstract][Full Text] [Related]
17. The effectiveness and cost-effectiveness of carmustine implants and temozolomide for the treatment of newly diagnosed high-grade glioma: a systematic review and economic evaluation.
Garside R; Pitt M; Anderson R; Rogers G; Dyer M; Mealing S; Somerville M; Price A; Stein K
Health Technol Assess; 2007 Nov; 11(45):iii-iv, ix-221. PubMed ID: 17999840
[TBL] [Abstract][Full Text] [Related]
18. Cost-Effectiveness of Endovascular Stroke Therapy: A Patient Subgroup Analysis From a US Healthcare Perspective.
Kunz WG; Hunink MG; Sommer WH; Beyer SE; Meinel FG; Dorn F; Wirth S; Reiser MF; Ertl-Wagner B; Thierfelder KM
Stroke; 2016 Nov; 47(11):2797-2804. PubMed ID: 27758942
[TBL] [Abstract][Full Text] [Related]
19. Cost-effectiveness of endovascular repair, open repair, and conservative management of splenic artery aneurysms.
Hogendoorn W; Lavida A; Hunink MG; Moll FL; Geroulakos G; Muhs BE; Sumpio BE
J Vasc Surg; 2015 Jun; 61(6):1432-40. PubMed ID: 25827968
[TBL] [Abstract][Full Text] [Related]
20. Outcomes of reoperative open or endovascular interventions to treat patients with failing open mesenteric reconstructions for mesenteric ischemia.
Kanamori KS; Oderich GS; Fatima J; Sarac T; Cha S; Kalra M; De Martino R; Bower TC
J Vasc Surg; 2014 Dec; 60(6):1612-9.e1-2. PubMed ID: 25282699
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
